ONCOCYTE

$1.66 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About ONCOCYTE

Oncocyte Corporation operates as a molecular diagnostics company. The Company offers actionable answers at decision points across the cancer care continuum, as well as focuses on improving patient outcomes by accelerating and optimizing diagnosis and treatment. Oncocyte serves clients in the United States.

Stock Analysis

last close $2.19
1-mo return 1.4%
3-mo return -33.6%
avg daily vol. 550.39T
52-week high 6.57
52-week low 1.8
market cap. $174M
forward pe -
annual div. -
roe -51.5%
ltg forecast -
dividend yield -
annual rev. $5M
inst own. 62.1%
baraka

Subscribe now for daily local and international financial news

Subscribe